Sign Up to like & get recommendations! 0
Published in 2022 at "Birth Defects Research"
DOI: 10.1002/bdr2.2010
Abstract: Human stems cells have sparked many novel strategies for treating heart disease and for elucidating their underlying mechanisms. For example, arrhythmogenic right ventricular cardiomyopathy (ARVC) is an inherited heart muscle disorder that is associated with… read more here.
Sign Up to like & get recommendations! 0
Published in 2024 at "Clinical Cardiology"
DOI: 10.1002/clc.70051
Abstract: To perform a bibliometric analysis of publications of arrhythmogenic right ventricular cardiomyopathy (ARVC) from 1981 to 2023 to summarize the current publications and explore frontiers on this topic. read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "ESC Heart Failure"
DOI: 10.1002/ehf2.14218
Abstract: Our previous studies suggested that the complement system was critical in the prognosis of arrhythmogenic right ventricular cardiomyopathy (ARVC). The acylation‐stimulating protein (ASP), generated through the alternate complement pathway, was reported to regulate lipogenesis and… read more here.
Sign Up to like & get recommendations! 0
Published in 2025 at "Journal of Arrhythmia"
DOI: 10.1002/joa3.70204
Abstract: The identification of arrhythmogenic right ventricular cardiomyopathy (ARVC) patients at risk for fatal arrhythmic events is of great importance in clinical practice. Conflicting data exist regarding the role of electrophysiological study (EPS) in this setting.… read more here.
Sign Up to like & get recommendations! 0
Published in 2019 at "Journal of Interventional Cardiac Electrophysiology"
DOI: 10.1007/s10840-019-00594-z
Abstract: Purpose In arrhythmogenic right ventricular cardiomyopathy (ARVC), abnormal electroanatomic mapping (EAM) areas are proportional to extent of T-wave inversion on 12-lead ECG. We aimed to evaluate local repolarization changes and their relationship to EAM substrate… read more here.
Sign Up to like & get recommendations! 0
Published in 2021 at "Journal of applied genetics"
DOI: 10.1007/s13353-021-00647-y
Abstract: Arrhythmogenic right ventricular cardiomyopathy (ARVC) is mainly caused by mutations in genes encoding desmosomal proteins. Variants in plakophilin-2 gene (PKP2) are the most common cause of the disease, associated with conventional ARVC phenotype. The study… read more here.
Sign Up to like & get recommendations! 0
Published in 2021 at "HeartRhythm Case Reports"
DOI: 10.1016/j.hrcr.2021.05.014
Abstract: Clinical re-review of all suspected ARVC cases should always be performed, especially when more Introduction The underlying etiology of ventricular tachycardia (VT) is essential for developing proper risk stratification and treatment strategies. Assessment of an… read more here.
Sign Up to like & get recommendations! 0
Published in 2019 at "Heart rhythm"
DOI: 10.1016/j.hrthm.2018.10.016
Abstract: BACKGROUND The comparative efficacy of antiarrhythmic drug (AAD) therapy vs ventricular tachycardia (VT) ablation in arrhythmogenic right ventricular cardiomyopathy (ARVC) is unknown. OBJECTIVE We compared outcomes of AAD and/or β-blocker (BB) therapy with those of… read more here.
Sign Up to like & get recommendations! 0
Published in 2020 at "Heart rhythm"
DOI: 10.1016/j.hrthm.2020.01.035
Abstract: BACKGROUND Arrhythmogenic right ventricular cardiomyopathy type V (ARVC-5) is the most aggressive heterozygous form of ARVC. It is predominantly caused by a fully penetrant mutation (p.S358L) in the non-desmosomal gene TMEM43 - endemic to Newfoundland,… read more here.
Sign Up to like & get recommendations! 2
Published in 2020 at "Heart rhythm"
DOI: 10.1016/j.hrthm.2020.02.028
Abstract: BACKGROUND High level exercise has been associated with a malignant phenotype in desmosomal and genotype negative forms of arrhythmogenic right ventricular cardiomyopathy (ARVC). This is the first study to examine this issue with ARVC secondary… read more here.
Sign Up to like & get recommendations! 0
Published in 2021 at "Heart rhythm"
DOI: 10.1016/j.hrthm.2021.03.018
Abstract: BACKGROUND Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) is an important cause of sudden cardiac death in young people and athletes. Thus far, no treatment has proven to slow the progression of the disease. Preload reducing agents… read more here.